|
|||||
|
|
Efficacy of liraglutide added to sodium-glucose cotransporter-2 inhibitors in type 2 diabetes,stratified by baseline characteristics: Post-hoc analysis of LIRA-ADD2SGLT2i |
|
| Authors: | Lawrence Blonde MD Udi Fainberg MD Margit S. Kaltoft MD Ofri Mosenzon MD Chethana Ramesh MSc Rosangela Rea MD |
| Affiliation: | 1. Ochsner Diabetes Clinical Research Unit, Frank Riddick Diabetes Institute, Department of Endocrinology, Ochsner Medical Center, New Orleans, Louisiana, USA;2. Novo Nordisk A/S, Søborg, Denmark;3. Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel;4. Novo Nordisk, Bangalore, India;5. Hospital de Clínicas, Universidade Federal do Paraná (SEMPR), Curitiba, Brazil |
| Abstract: | |
| Keywords: | antidiabetic drug GLP-1 analogue glycaemic control liraglutide SGLT2 inhibitor type 2 diabetes |